Aveanna ‘not a buyer of hospices’ due to high multiples

Aveanna ‘not a buyer of hospices’ due to high multiples 
Hospice News; by Jim Parker; 10/10/25 
Aveanna Healthcare Holdings (Nasdaq: AVAH) is hungry for acquisitions, but hospice transactions are likely not on the menu. Aveanna’s expanding hospice and home health business has largely included a focus on organic growth and tuck-ins across its existing geographic markets. Acquisitions could make up a larger portion of its strategy on the near horizon, according to CEO Jeff Shaner. The company has been less active on the M&A front in recent years, taking a cautious approach to growth, he previously indicated. However, the company is not in the market for hospices due to high valuations in the space compared to other health care sectors like home health or private duty services.